Phil Johnson calls for fairness in PTAB proceedings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Phil Johnson calls for fairness in PTAB proceedings

ptab-web-icon.jpg

In a session at the AIPLA Annual Meeting, David Kappos said that Federal Circuit decisions will show whether the Patent and Trial Appeal Board (PTAB) is on the right track while Phil Johnson stressed that the proceedings must be perceived as fair

Kappos, partner at Cravath Swaine & Moore, and former director of the USPTO, praised the job the PTAB has done in keeping up with its higher-than-expected workload. He said it was too early to assess how the Board is doing in its ­decisions.

“One thing I would say is that the ultimate arbiter of whether the PTAB is getting these things right is going to be the Federal Circuit and, to some extent, the Supreme Court," Kappos said, “We need to reserve judgment and look to the court decisions and also look to the basis of the court decisions. I would see it as OK if the agency gets reversed on close calls, judgment calls on things like 103 decisions. I certainly ­wouldn’t see it as OK if you start getting into ­arbitrary and capricious or abuse of ­discretion kinds of things, though I see no indication that is a problem yet.”

The USPTO asked for feedback on PTAB proceedings and received 37 comments by its deadline last week. Quite a few of the comments raised concerns about the constraints under the proceedings, such as the lack of ability to amend. Many believe the proceedings are weighted too much in petitioners’ favor and are unfair to patent owners.

“What is really at stake here is: how fair are these proceedings going to be perceived as?” Johnson , senior vice-president for intellectual property at Johnson & Johnson, said. “Ultimately if they are perceived as being unfair there will be reactions, whether the reaction is from the Federal Circuit or whether the reaction is from Congress, or whether the reaction is from businesses who say, ‘If every important patent I get can easily be invalidated by taking it into IPR, why should I be doing anything in the patent system? Why shouldn’t I be doing trade secrets or whatever my other alternatives are?

“We all have a strong interest in making sure these proceedings are not only fair but also that they are perceived to be fair. If it may make a difference in perception on the side of fairness, that is something worth going for. These are extremely important issues and I am really glad the PTO has taken the step to go out and get comments. Frankly, if it gets messed up we could lose even more credibility with the patent system itself and that to me is a big long-term risk.”

more from across site and SHARED ros bottom lb

More from across our site

Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Gift this article